Director, Marketing Promotions
Kyverna Therapeutics
Director, Marketing Promotions
Kyverna Therapeutics
T cell therapies for autoimmune diseases
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.
Title: Director, Marketing Promotions
Reports To: VP of Marketing
Location: Emeryville, CA (Hybrid: 2 days a week) or West Coast Remote
Travel: Approximately 25%
Position Overview
Kyverna Therapeutics is seeking a Director, Marketing Promotions to lead the strategic development, execution, and governance of promotional strategies and activities for miv-cel and future pipeline products. This role is responsible for building and scaling promotional capabilities in a manner that is patient-centric, scientifically grounded, and fully compliant with global regulatory and ethical standards.
The Director will partner closely with Sales, Medical Affairs, Regulatory, Legal, Compliance, Market Access, and Commercial leadership to ensure that all promotional initiatives effectively communicate Kyverna’s value proposition and differentiation while maintaining the highest standards of scientific accuracy and integrity. This individual will play a critical leadership role in preparing Kyverna for launch and supporting lifecycle management as the organization transitions from development-stage to commercial operations.
The nationalsalary range for this position is $220K to $250K USD annually. This salary range is an estimate of what we reasonably expect to pay for this position, and the actual salary may vary based on various factors that may include but are not limited to quality and length of experience, education, geographic location and alignment with market data. This position is also eligible for bonus, benefits, and participation in the company’s stock plan.
T cell therapies for autoimmune diseases
Kyverna Therapeutics develops cell therapies for autoimmune diseases. The company uses synthetic biology, immunology, and cell engineering to create engineered T cells designed to target and modulate the root causes of autoimmunity. Its therapies are intended to be given by a single infusion to achieve long-lasting disease control, reducing or eliminating the need for ongoing treatments. Kyverna pursues in-licensing and collaboration opportunities to broaden its technology and capabilities and to advance its therapies toward patients through development and sales to patients and healthcare providers. The core goal is to provide durable, well-tolerated treatments that can offer substantial, long-term relief for people with autoimmune diseases.
Explore more opportunities at Kyverna Therapeutics